Park City Biotech Investors
Where Accredited Investors Meet the Future of Health
PCBI is a national biotech angel network specializing in AI driven, cost-reducing healthcare innovations with a proven exit market driven by Big Pharma acquisitions.
A once-in-a-generation shift in drug development is creating extraordinary investment opportunities — and PCBI exists to connect accredited investors directly to them.
We specialize exclusively in biotech startups that use AI, computational biology, and quantum biology to dramatically reduce the $2B+ average cost of bringing a drug to market. Our curated virtual pitch model means you only see deals relevant to your interests — no wasted time, no geographic barriers.
The exit market has never been stronger. With Big Pharma R&D productivity at just 1.2%, major players are acquiring innovative startups to refill their pipelines. PCBI-backed ventures are built for exactly that outcome.
